Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|16|10|1325-1338

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.16, Iss.10, 2016-08, pp. : 1325-1338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin

By Ma Rundi   Song Gang   You Wenbing   Yu Lijian   Su Weiming   Liao Mingneng   Zhang Yongping   Huang Laizhen   Zhang Xiaoyu   Yu Tingxi  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. : 559-568

Springer Publishing Company

Access to resources Recommend Favorite

Tubulin Inhibitors: A Patent Survey

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Iss. 2, 2014-05 ,pp. : 176-220

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of P-gp Inhibitors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 4, 2009-05 ,pp. : 415-436

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Hsp90 Inhibitors as Antitumor Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 7, 2008-10 ,pp. : 761-782

Bentham Science Publishers

Access to resources Recommend Favorite

Peptidomimetic Design of CDK Inhibitors Targeting theRecruitment Site of the Cyclin Subunit

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 1, 2003-01 ,pp. : 57-69

Bentham Science Publishers

Access to resources Recommend Favorite